China Medical System Holdings Limited (SGX:8A8)

Singapore flag Singapore · Delayed Price · Currency is SGD
2.180
-0.010 (-0.46%)
At close: Dec 29, 2025
Market Cap5.21B
Revenue (ttm)1.40B
Net Income (ttm)293.38M
Shares Outn/a
EPS (ttm)0.12
PE Ratio17.75
Forward PE15.40
Dividend0.03 (1.28%)
Ex-Dividend DateSep 1, 2025
Volume36,000
Average Volume29,270
Open2.130
Previous Close2.190
Day's Range2.130 - 2.180
52-Week Range2.050 - 2.550
Betan/a
RSI42.88
Earnings DateMar 15, 2026

About SGX:8A8

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 6,141
Stock Exchange Singapore Exchange
Ticker Symbol 8A8
Full Company Profile

Financial Performance

In 2024, SGX:8A8's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.